Cardiol Therapeutics: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (CRDL)
Cardiol Therapeutics Inc is among the group of top performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price grow at a faster rate than the rest of the market so far this year.
This report is generated monthly. It highlights the 25 companies with the greatest percentage increase in share price year-to-date. Stocks in this category are generally held for appreciation or speculation.
Companies experiencing dramatic increases in share price can do so for a variety of reasons – including bullish changes in sector outlook, potential corporate takeover, or the company has restructured and earnings are better than expected.
Symbol | Name | Total Return | Period |
---|---|---|---|
MDNA | Medicenna Therapeutics Corp | 392.857143 | YTD |
AIDX | Healwell AI Inc | 213.333333 | YTD |
XLY | Auxly Cannabis Group Inc | 200 | YTD |
CRDL | Cardiol Therapeutics Inc | 161.818182 | YTD |
EDR | Endeavour Silver Corp | 150.384615 | YTD |
AAB | Aberdeen International Inc | 150 | YTD |
PYR | PyroGenesis Canada Inc | 130.232558 | YTD |
GTWO | G2 Goldfields Inc | 121.917808 | YTD |
CEU | CES Energy Solutions Corp | 120.869565 | YTD |
GATO | Gatos Silver Inc | 120.441347 | YTD |
CLS | Celestica Inc | 115.743365 | YTD |
ASM | Avino Silver & Gold Mines Ltd | 113.043478 | YTD |
PPTA | Perpetua Resources Corp | 112.171838 | YTD |
GAU | Galiano Gold Inc | 111.382114 | YTD |
MSA | Mineros SA | 108.983587 | YTD |
JAG | Jaguar Mining Inc | 107.386364 | YTD |
SHLE | Source Energy Services Ltd | 105.872483 | YTD |
HRX | Heroux-Devtek Inc | 104.539474 | YTD |
DRX | ADF Group Inc | 104.33526 | YTD |
CPLF | Copperleaf Technologies Inc | 97.019868 | YTD |
OPT | Optiva Inc | 96.060606 | YTD |
FORA | VerticalScope Holdings Inc | 93.376068 | YTD |
PRL | Propel Holdings Inc | 90.285274 | YTD |
CEMX | Cematrix Corp | 85.454545 | YTD |
GTE | Gran Tierra Energy Inc | 84.408602 | YTD |
All data provided as of July 18, 2024.
More about Cardiol Therapeutics Inc
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases.
Cardiol Therapeutics Inc is listed under CRDL on the Toronto Stock Exchange.
Artificial intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.